Ascendis Pharma A/S
SEC Filing List
ASND CIK: 0001612042
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Smith Scott Thomas | Latham & Watkins LLP (Filing Agent) /fa | 06/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Bienaime Jean Jacques | Latham & Watkins LLP (Filing Agent) /fa | 06/01/2026 | |
| 4 | Statement of changes in beneficial owner... | Smith Scott Thomas | Latham & Watkins LLP (Filing Agent) /fa | 06/01/2026 | |
| 3/A | Amendment to the Initial statement of be... | Smith Scott Thomas | Latham & Watkins LLP (Filing Agent) /fa | 06/01/2026 | |
| 4 | Statement of changes in beneficial owner... | Bienaime Jean Jacques | Latham & Watkins LLP (Filing Agent) /fa | 05/27/2026 | |
| SD | Specialized Disclosure Report filed purs... | Ascendis Pharma A/s | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/22/2026 | |
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | 05/14/2026 | ||||
| 6-K | Current report of foreign issuer pursuan... | Ascendis Pharma A/s | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/13/2026 | |
| 4 | Statement of changes in beneficial owner... | Jensen Flemming Steen | Latham & Watkins LLP (Filing Agent) /fa | 05/12/2026 | |
| No record found. | |||||
| Load More | |||||
